Drug Shortage Report for CIPRO XL

Last updated on 2022-03-02 History
Report ID 51877
Drug Identification Number 02251787
Brand name CIPRO XL
Common or Proper name Ciprofloxacin Hydrochloride and Ciprofloxacin Extended Release
Company Name BAYER INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CIPROFLOXACIN
Strength(s) 1000MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 50's
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-30
Actual start date 2020-04-29
Estimated end date
Actual end date 2022-03-01
Shortage status Resolved
Updated date 2022-03-02
Company comments Discontinued as of March 1, 2022
Health Canada comments
Tier 3 Status No
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-03-02 English Compare
v13 2021-11-16 French Compare
v12 2021-11-16 English Compare
v11 2019-03-29 French Compare
v10 2019-03-29 English Compare
v9 2019-01-25 French Compare
v8 2019-01-25 English Compare
v7 2018-12-14 French Compare
v6 2018-12-14 English Compare
v5 2018-08-29 French Compare
v4 2018-08-29 English Compare
v3 2018-07-31 English Compare
v2 2018-06-07 French Compare
v1 2018-06-07 English Compare

Showing 1 to 14 of 14